Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018)
Analysis
Teva Pharmaceutical Industries (TEVA) FCF Payout Ratio (QoQ) (2009 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2018 | -93.87% |
| Dec 31, 2017 | -30.34% |
| Sep 30, 2017 | -85.20% |
| Jun 30, 2017 | 127.19% |
| Mar 31, 2017 | -268.18% |
| Dec 31, 2016 | -619.29% |
| Sep 30, 2016 | -30.30% |
| Jun 30, 2016 | 54.28% |
| Mar 31, 2016 | 20.19% |
| Dec 31, 2015 | -31.77% |
| Sep 30, 2015 | 41.54% |
| Jun 30, 2015 | -11.45% |
| Mar 31, 2015 | 32.43% |
| Dec 31, 2014 | -22.78% |
| Sep 30, 2014 | -30.15% |
| Jun 30, 2014 | -19.69% |
| Mar 31, 2014 | -21.35% |
| Dec 31, 2013 | -55.02% |
| Sep 30, 2013 | 196.43% |
| Jun 30, 2013 | 22.96% |